Why Exelixis, Inc. (EXEL) Skyrocketed On Wednesday

Angelica Ballesteros

Wed, May 14, 2025, 4:56 PM 2 min read

We precocious published a database of These 10 Firms Blowing Up by Double Digits Today. In this article, we are going to instrumentality a look astatine wherever Exelixis, Inc. (NASDAQ:EXEL) stands against different firms blowing up by treble digits today.

Ten idiosyncratic stocks soared by treble digits connected Wednesday, outperforming a lackluster show among Wall Street’s indices, acknowledgment to the 90-day truce betwixt the US and China that continued to boost capitalist confidence.

In contrast, Wall Street’s indices were mixed, with the tech-heavy Nasdaq increasing 0.72 percent, followed by the S&P 500, up 0.10 percent. The Dow Jones declined by 0.21 percent.

In this article, we sanction Wednesday’s 10 best-performing stocks and item the reasons down their gains.

To travel up with the list, we considered lone the stocks with a $2-billion marketplace capitalization and $5-million trading volume.

A squad of scientists successful laboratory coats surrounded by pharmaceuticals and aesculapian equipment, researching a life-saving oncology-focused biotechnology.

Exelixis soared by 20.84 percent connected Wednesday to decorativeness astatine $44.65 each pursuing a beardown net show successful the archetypal 3 months, coupled with a much optimistic outlook for the remainder of the year.

In its latest net release, Exelixis, Inc. (NASDAQ:EXEL) said nett income expanded by 332 percent to $160 cardinal from $37 cardinal successful the aforesaid play past year.

Revenues, connected the different hand, grew by 30 percent to $555 cardinal from $425 cardinal year-on-year, chiefly owed to an summation successful income measurement and an summation successful mean nett selling price.

“Exelixis delivered outstanding fiscal show successful the archetypal 4th of 2025, driven by accelerating maturation successful CABOMETYX demand, caller diligent starts, and revenues,” said President and CEO Michael Morrissey.

Based connected the beardown figures, the institution has raised its maturation outlook for nett merchandise revenues and full revenues, some by $100 cardinal for the afloat year.

Overall, EXEL ranks 1st on our database of firms blowing up by treble digits today. While we admit the imaginable of EXEL arsenic an investment, our condemnation lies successful the content that AI stocks clasp greater committedness for delivering higher returns and doing truthful wrong a shorter clip frame. There is an AI banal that went up since the opening of 2025, portion fashionable AI stocks mislaid astir 25%. If you are looking for an AI banal that is much promising than EXEL but that trades astatine little than 5 times its earnings, cheque retired our study astir this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.